Company profile: Cephalon
1.1 - Company Overview
Company description
- Provider of biopharmaceutical discovery, development, and commercialization of medications to improve quality of life worldwide. Founded in 1987, the company delivers first-in-class and best-in-class medicines across several therapeutic areas.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cephalon
Actimis Pharmaceuticals
HQ: United States
Website
- Description: Provider of small molecule therapeutics for respiratory and inflammatory disorders; a start-up biopharmaceutical company spun off from Bayer Healthcare AG's respiratory diseases therapeutic research portfolio, founded by Dr. Kevin Bacon.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Actimis Pharmaceuticals company profile →
FibroBiologics
HQ: United States
Website
- Description: Provider of fibroblast cell-based regenerative therapies for chronic diseases, including multiple sclerosis (immune modulation and tissue regeneration), CybroCell universal donor cellular product for degenerative disc disease (disc regeneration and inflammation reduction), wound healing, and therapies to improve and extend the productive life of the thymus and enhance spleen function.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FibroBiologics company profile →
Noven Pharmaceuticals
HQ: United States
Website
- Description: Provider of specialty prescription pharmaceutical products, engaged in the research, development, manufacture, marketing and sale of these products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Noven Pharmaceuticals company profile →
Redx Pharma
HQ: United Kingdom
Website
- Description: Provider of drug discovery and development advancing clinical-stage assets Zelasudil (ROCK2 inhibitor for idiopathic pulmonary fibrosis and fibrotic diseases), Zamaporvint (Porcupine inhibitor for Wnt-ligand driven cancer), RXC008 (GI-targeted pan-ROCK for fibrostenotic Crohn's), and a Drug Discovery Engine supporting programs in fibrosis and oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Redx Pharma company profile →
Ablynx
HQ: Belgium
Website
- Description: Provider of a proprietary Nanobody® technology platform for the discovery and development of therapeutic nanobodies—small single-domain antibody fragments—targeting serious human diseases including inflammation, haematology, oncology and pulmonary disease, with approximately 25 projects in the pipeline.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ablynx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cephalon
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cephalon
2.2 - Growth funds investing in similar companies to Cephalon
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cephalon
4.2 - Public trading comparable groups for Cephalon
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →